BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, Liu Z, Xu Q, Liu S, Xiao D, Tao Y. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer 2020;19:47. [PMID: 32122355 DOI: 10.1186/s12943-020-01171-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Khan P, Siddiqui JA, Lakshmanan I, Ganti AK, Salgia R, Jain M, Batra SK, Nasser MW. RNA-based therapies: A cog in the wheel of lung cancer defense. Mol Cancer 2021;20:54. [PMID: 33740988 DOI: 10.1186/s12943-021-01338-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vangoor VR, Gomes-Duarte A, Pasterkamp RJ. Long non-coding RNAs in motor neuron development and disease. J Neurochem 2021;156:777-801. [PMID: 32970857 DOI: 10.1111/jnc.15198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wu W, Zhang S, He J. The Mechanism of Long Non-coding RNA in Cancer Radioresistance/Radiosensitivity: A Systematic Review. Front Pharmacol 2022;13:879704. [DOI: 10.3389/fphar.2022.879704] [Reference Citation Analysis]
4 Zhang J, Zhang L, Wang J, Zhao J, Zhao X, Zhang C, Han P, Geng C. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis. Hum Cell 2022. [PMID: 35179718 DOI: 10.1007/s13577-022-00685-6] [Reference Citation Analysis]
5 Zuo J, Zhang Z, Li M, Yang Y, Zheng B, Wang P, Huang C, Zhou S. The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role. Mol Cancer 2022;21:30. [PMID: 35081965 DOI: 10.1186/s12943-021-01488-3] [Reference Citation Analysis]
6 Ahmadpour S, Taghavi T, Sheida A, Tamehri Zadeh SS, Hamblin MR, Mirzaei H. Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma. Epigenomics 2022. [PMID: 35473299 DOI: 10.2217/epi-2021-0439] [Reference Citation Analysis]
7 Qiu H, Zhang L, Yi T, Yang K, Gong Y, Xie C. Retracted: Long non-coding RNA TP73-AS1 facilitates progression and radioresistance in lung cancer cells by the miR-216a-5p/CUL4B axis with exosome involvement. Thorac Cancer 2021;12:409. [PMID: 32841514 DOI: 10.1111/1759-7714.13602] [Reference Citation Analysis]
8 Wang Y, Wang Y, Qin Z, Cai S, Yu L, Hu H, Zeng S. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opin Drug Metab Toxicol 2021;17:291-306. [PMID: 33544643 DOI: 10.1080/17425255.2021.1887139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen D, Ping S, Xu Y, Wang M, Jiang X, Xiong L, Zhang L, Yu H, Xiong Z. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications. Front Cell Dev Biol 2021;9:732036. [PMID: 34805143 DOI: 10.3389/fcell.2021.732036] [Reference Citation Analysis]
10 Li Z, Lü M, Zhou Y, Xu L, Jiang Y, Liu Y, Li X, Song M. Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review. Onco Targets Ther 2021;14:503-18. [PMID: 33500626 DOI: 10.2147/OTT.S294378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Ashrafizadeh M, Mirzaei S, Hushmandi K, Rahmanian V, Zabolian A, Raei M, Farahani MV, Goharrizi MASB, Khan H, Zarrabi A, Samarghandian S. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects. Life Sci 2021;278:119649. [PMID: 34043989 DOI: 10.1016/j.lfs.2021.119649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ma M, Li L, Long F, Xiao H, Lu M, Lin C. MiR-133b inhibits colorectal cancer metastasis via lncRNA-LUCAT1. Future Oncol 2021;17:1013-23. [PMID: 33541136 DOI: 10.2217/fon-2020-0420] [Reference Citation Analysis]
13 Outeiro-Pinho G, Barros-Silva D, Correia MP, Henrique R, Jerónimo C. Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs. Cancers (Basel) 2020;12:E2214. [PMID: 32784737 DOI: 10.3390/cancers12082214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Hwang GR, Yuen JG, Ju J. Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development. Int J Mol Sci 2021;22:1624. [PMID: 33562727 DOI: 10.3390/ijms22041624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yuan Y, Jiang X, Tang L, Wang J, Zhang D, Cho WC, Duan L. FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma. Front Mol Biosci 2022;8:785767. [DOI: 10.3389/fmolb.2021.785767] [Reference Citation Analysis]
16 Alvarez-Meythaler JG, Garcia-Mayea Y, Mir C, Kondoh H, LLeonart ME. Autophagy Takes Center Stage as a Possible Cancer Hallmark. Front Oncol 2020;10:586069. [PMID: 33194736 DOI: 10.3389/fonc.2020.586069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
17 Peng Q, Wang J. Non-coding RNAs in melanoma: Biological functions and potential clinical applications. Mol Ther Oncolytics 2021;22:219-31. [PMID: 34514101 DOI: 10.1016/j.omto.2021.05.012] [Reference Citation Analysis]
18 Si L, Bai J, Fu H, Qiu H, Guo R. The functions and potential roles of extracellular vesicle noncoding RNAs in gynecological malignancies. Cell Death Discov 2021;7:258. [PMID: 34552067 DOI: 10.1038/s41420-021-00645-3] [Reference Citation Analysis]
19 Le P, Romano G, Nana-Sinkam P, Acunzo M. Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer. Cancers (Basel) 2021;13:1372. [PMID: 33803619 DOI: 10.3390/cancers13061372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang H, Lu B. The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis. Cancers (Basel) 2020;12:E2926. [PMID: 33050642 DOI: 10.3390/cancers12102926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Pancewicz J. A brief overview of clinical significance of novel Notch2 regulators. Mol Cell Oncol 2020;7:1776084. [PMID: 32944632 DOI: 10.1080/23723556.2020.1776084] [Reference Citation Analysis]
22 Fernandez-Rozadilla C, Simões AR, Lleonart ME, Carnero A, Carracedo Á. Tumor Profiling at the Service of Cancer Therapy. Front Oncol 2020;10:595613. [PMID: 33505911 DOI: 10.3389/fonc.2020.595613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Xu Z, Peng B, Cai Y, Wu G, Huang J, Gao M, Guo G, Zeng S, Gong Z, Yan Y. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives. Biochem Pharmacol 2020;182:114258. [PMID: 33017575 DOI: 10.1016/j.bcp.2020.114258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Liu W, Miao C, Zhang S, Liu Y, Niu X, Xi Y, Guo W, Chu J, Lin A, Liu H, Yang X, Chen X, Zhong C, Ma Y, Wang Y, Zhu S, Liu S, Tan W, Lin D, Wu C. VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduct Target Ther 2021;6:322. [PMID: 34462423 DOI: 10.1038/s41392-021-00735-9] [Reference Citation Analysis]
25 He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 2020;16:2628-47. [PMID: 32792861 DOI: 10.7150/ijbs.47203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
26 Wang J, Uddin MN, Hao JP, Chen R, Xiang YX, Xiong DQ, Wu Y. Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia. Front Genet 2021;12:723001. [PMID: 34777462 DOI: 10.3389/fgene.2021.723001] [Reference Citation Analysis]
27 Micallef I, Baron B. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Noncoding RNA 2021;7:24. [PMID: 33807355 DOI: 10.3390/ncrna7020024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Chen J, Gu J, Tang M, Liao Z, Tang R, Zhou L, Su M, Jiang J, Hu Y, Chen Y, Zhou Y, Liao Q, Xiong W, Zhou J, Tang Y, Nie S. Regulation of cancer progression by circRNA and functional proteins. J Cell Physiol 2021. [PMID: 34676546 DOI: 10.1002/jcp.30608] [Reference Citation Analysis]
29 Wang J, Da C, Su Y, Song R, Bai Z. MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b. Biochem Biophys Res Commun 2021;556:31-8. [PMID: 33836345 DOI: 10.1016/j.bbrc.2021.02.084] [Reference Citation Analysis]
30 Wang S, Ping M, Song B, Guo Y, Li Y, Jia J. Exosomal CircPRRX1 Enhances Doxorubicin Resistance in Gastric Cancer by Regulating MiR-3064-5p/PTPN14 Signaling. Yonsei Med J 2020;61:750-61. [PMID: 32882759 DOI: 10.3349/ymj.2020.61.9.750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Dsouza VL, Adiga D, Sriharikrishnaa S, Suresh PS, Chatterjee A, Kabekkodu SP. Small nucleolar RNA and its potential role in breast cancer - A comprehensive review. Biochim Biophys Acta Rev Cancer 2021;1875:188501. [PMID: 33400969 DOI: 10.1016/j.bbcan.2020.188501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Xie H, Liu S, Zhang Z, Chen P, Tao Y. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma. J Cancer 2020;11:5768-81. [PMID: 32913470 DOI: 10.7150/jca.44573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Xu XF, Yang XK, Song Y, Chen BJ, Yu X, Xu T, Chen ZL. Dysregulation of Non-coding RNAs mediates Cisplatin Resistance in Hepatocellular Carcinoma and therapeutic strategies. Pharmacol Res 2021;:105906. [PMID: 34543740 DOI: 10.1016/j.phrs.2021.105906] [Reference Citation Analysis]
34 Sun M, Ju J, Ding Y, Zhao C, Tian C. The signaling pathways regulated by KRAB zinc-finger proteins in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188731] [Reference Citation Analysis]
35 Wang G, Duan P, Liu F, Wei Z. Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis. Bioengineered 2021;12:11555-66. [PMID: 34889164 DOI: 10.1080/21655979.2021.2010372] [Reference Citation Analysis]
36 Song J, Zhang S, Sun Y, Gu J, Ye Z, Sun X, Tang Q. A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer. J Oncol 2021;2021:4338838. [PMID: 34594376 DOI: 10.1155/2021/4338838] [Reference Citation Analysis]
37 Mishra R, Patel H, Alanazi S, Kilroy MK, Garrett JT. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects. Int J Mol Sci 2021;22:3464. [PMID: 33801659 DOI: 10.3390/ijms22073464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Mei J, Lin W, Li S, Tang Y, Ye Z, Lu L, Wen Y, Kan A, Zou J, Yu C, Wei W, Guo R. Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway. J Exp Clin Cancer Res 2022;41:5. [PMID: 34980201 DOI: 10.1186/s13046-021-02197-x] [Reference Citation Analysis]
39 Xia M, Zu X, Chen Z, Wen G, Zhong J. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance. Cancer Lett 2021;523:100-10. [PMID: 34601022 DOI: 10.1016/j.canlet.2021.09.038] [Reference Citation Analysis]
40 Zheng Y, Luo Y, Chen X, Li H, Huang B, Zhou B, Zhu L, Kang X, Geng W. The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors. Mol Cancer 2021;20:49. [PMID: 33673851 DOI: 10.1186/s12943-021-01341-7] [Reference Citation Analysis]
41 Serra M, Hattinger CM, Pasello M, Casotti C, Fantoni L, Riganti C, Manara MC. Impact of ABC Transporters in Osteosarcoma and Ewing's Sarcoma: Which Are Involved in Chemoresistance and Which Are Not? Cells 2021;10:2461. [PMID: 34572110 DOI: 10.3390/cells10092461] [Reference Citation Analysis]
42 Chen Z, Hu Z, Sui Q, Huang Y, Zhao M, Li M, Liang J, Lu T, Zhan C, Lin Z, Sun F, Wang Q, Tan L. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma. Int J Biol Sci 2022;18:522-35. [PMID: 35002507 DOI: 10.7150/ijbs.67556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Zhu J, Guan J, Ji X, Song Y, Xu X, Wang Q, Zhang Q, Guo R, Wang R, Zhang R. A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction. Mol Genet Genomics 2022. [PMID: 35218396 DOI: 10.1007/s00438-022-01869-3] [Reference Citation Analysis]
44 Sharma U, Murmu M, Barwal TS, Tuli HS, Jain M, Prakash H, Kaceli T, Jain A, Bishayee A. A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response. Current Oncology 2022;29:2326-49. [DOI: 10.3390/curroncol29040189] [Reference Citation Analysis]
45 Fan L, Li B, Li Z, Sun L. Identification of Autophagy Related circRNA-miRNA-mRNA-Subtypes Network With Radiotherapy Responses and Tumor Immune Microenvironment in Non-small Cell Lung Cancer. Front Genet 2021;12:730003. [PMID: 34567080 DOI: 10.3389/fgene.2021.730003] [Reference Citation Analysis]
46 Chen S, Ben S, Xin J, Li S, Zheng R, Wang H, Fan L, Du M, Zhang Z, Wang M. The biogenesis and biological function of PIWI-interacting RNA in cancer. J Hematol Oncol 2021;14:93. [PMID: 34118972 DOI: 10.1186/s13045-021-01104-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hu S, Zheng W, Jin L. Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1. J Nat Med 2021;75:156-66. [PMID: 33219447 DOI: 10.1007/s11418-020-01469-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Shan DD, Zheng QX, Wang J, Chen Z. Small nucleolar RNA host gene 3 functions as a novel biomarker in liver cancer and other tumour progression. World J Gastroenterol 2022; 28(16): 1641-1655 [DOI: 10.3748/wjg.v28.i16.1641] [Reference Citation Analysis]
49 Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y, Cheng Z, Wang X, Wang Y, Liu T, Wang J, Liu L. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin. Mol Cancer 2021;20:162. [PMID: 34893064 DOI: 10.1186/s12943-021-01455-y] [Reference Citation Analysis]
50 Xu JL, Yuan L, Tang YC, Xu ZY, Xu HD, Cheng XD, Qin JJ. The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe? Front Cell Dev Biol 2020;8:621428. [PMID: 33344463 DOI: 10.3389/fcell.2020.621428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
51 Drillis G, Goulielmaki M, Spandidos DA, Aggelaki S, Zoumpourlis V. Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies. Oncol Lett 2021;21:393. [PMID: 33777216 DOI: 10.3892/ol.2021.12654] [Reference Citation Analysis]
52 Li J, Zou J, Wan X, Sun C, Peng F, Chu Z, Hu Y. The Role of Noncoding RNAs in B-Cell Lymphoma. Front Oncol 2020;10:577890. [PMID: 33194698 DOI: 10.3389/fonc.2020.577890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Oghabi Bakhshaiesh T, Esmaeili R. Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review. Cell Cycle 2022;:1-11. [PMID: 35108162 DOI: 10.1080/15384101.2022.2035915] [Reference Citation Analysis]
54 Liu L, Dai A, Zhang Z, Ning M, Han D, Li L, Li Z. LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p. Aging (Albany NY) 2021;13:21191-201. [PMID: 34496348 DOI: 10.18632/aging.203403] [Reference Citation Analysis]
55 Hu F, Niu Y, Mao X, Cui J, Wu X, Simone CB 2nd, Kang HS, Qin W, Jiang L. tsRNA-5001a promotes proliferation of lung adenocarcinoma cells and is associated with postoperative recurrence in lung adenocarcinoma patients. Transl Lung Cancer Res 2021;10:3957-72. [PMID: 34858784 DOI: 10.21037/tlcr-21-829] [Reference Citation Analysis]
56 Wang Y, Huang Z, Li B, Liu L, Huang C. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer. Front Endocrinol 2022;13:863541. [DOI: 10.3389/fendo.2022.863541] [Reference Citation Analysis]
57 ZeinElAbdeen YA, AbdAlSeed A, Youness RA. Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer. J Mammary Gland Biol Neoplasia 2022. [PMID: 35146629 DOI: 10.1007/s10911-022-09511-z] [Reference Citation Analysis]
58 Montico B, Giurato G, Pecoraro G, Salvati A, Covre A, Colizzi F, Steffan A, Weisz A, Maio M, Sigalotti L, Fratta E. The pleiotropic role of circular and long noncoding RNAs in cutaneous melanoma. Mol Oncol 2021. [PMID: 34080276 DOI: 10.1002/1878-0261.13034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]